Biologics

Merola JF, Armstrong A, Khattri S, Paek SY, Padilla B, Yue C, Photowala H, Kaplan B, Kristensen LE. Efficacy of risankizumab across subgroups in patients[...]

By sjmartinez • April 18, 2024

Armstrong A, González-Cantero A, Khattri S, Muzy G, Malatestinic WN, Lampropoulou A, Feely M, See SK, Mert C, Blauvelt A. Comparing Achievement of National Psoriasis[...]

By sjmartinez • March 24, 2024

Vaccination Recommendations for Adults Receiving Biologics and Oral Therapies for Psoriasis and Psoriatic Arthritis: Delphi Consensus from the Medical Board of the National Psoriasis Foundation[...]

By sjmartinez • February 9, 2024

Armstrong AW, Jayade S, Rege S, Joshi N, Patel V, Kalirai S, Wolin D, Boyle K, Patel D, Seigel L. Evaluating Treatment Choice in Patients[...]

By sjmartinez • January 23, 2024

Armstrong AW, Warren RB, Zhong Y, Zhuo J, Cichewicz A, Kadambi A, Junqueira D, Westley T, Kisa R, Daamen C, Augustin M. Short-, Mid-, and[...]

By sjmartinez • October 7, 2023

Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S, Zheng K, Syal G, Ha C, Fleshner P, McGovern D, Sauk JS, Limketkai[...]

By sjmartinez • July 25, 2023

Kellogg C, Smogorzewski J. Update on Atopic Dermatitis. Adv Pediatr. 2023 Aug;70(1):157-170. doi: 10.1016/j.yapd.2023.03.006. Epub 2023 May 5. PMID: 37422293.

By sjmartinez • July 9, 2023